Summary of Significant Accounting Policies (Details) - Schedule of Outstanding Common Stock Equivalents have been Excluded from the Calculation of Net Loss Per Share - shares	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total potentially dilutive securities	6,213,052	3,709,427
Warrants to purchase shares of Common Stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total potentially dilutive securities	2,003,649	2,006,243
Unvested restricted stock units to be settled in shares of Common Stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total potentially dilutive securities	163,922	127,981
Shares of Common Stock issuable upon conversion of convertible notes [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total potentially dilutive securities	3,588,102	1,117,687
Shares of Common Stock issuable upon conversion of Series B Preferred Stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total potentially dilutive securities	2,971	2,971
Shares of Common Stock issuable upon conversion of Series C Preferred Stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total potentially dilutive securities	454,408	454,545